Ancient DNA May Fuel Cancer; ASCO Appeals to Oncologists; Pesticide Cancer Risk

[MEDPAGE TODAY]( Oncology Update Friday, July 26, 2024 [Ancient DNA May Fuel Cancer; ASCO Appeals to Oncologists; Pesticide Cancer Risk]( [FDA Panel Supports More Clarity in NSCLC Perioperative Immunotherapy Trials]( [These Athletes Weren't Doping. Their Genes Made It Look Like They Did.]( ['Next Berlin Patient' Adds to Small but Growing Number of People Cured of HIV]( [Two Tests Better Than One for Detecting Anal Cancer in People With HIV]( ADVERTISEMENT Exclusives & Features [Gynecology Queries Surged After Barbie Movie Release]( [Fauci's Hopes for D.C.: Be Prepared and Stick to the Evidence]( [Chatbots Crushed USMLE Step 3; Docs Use AI to Fight Insurers; AI for Nurses]( [The cellular hierarchy of acute myeloid leukemia informs personalized treatment]( Acute myeloid leukemia (AML) is characterized by malignant myeloid precursors that span a cellular hierarchy from dedifferentiated leukemic stem cells to mature blasts. While the diagnostic and... [READ MORE]( [Ruxolitinib for pediatric patients with treatment-naïve and steroid-refractory acute graft-versus-host disease (REACH4).]( In REACH4 (NCT03491215), a phase 1/2, open-label, single-arm, multicenter study, the pharmacokinetics (PK), efficacy, and safety of ruxolitinib were evaluated in treatment-naïve and... [READ MORE]( [KDM6A Regulates Immune Response Genes in Multiple Myeloma.]( The histone H3K27 demethylase KDM6A is a tumor suppressor in multiple cancers, including multiple myeloma (MM). We created isogenic MM cells disrupted for KDM6A and tagged the endogenous protein to... [READ MORE]( [A predictive model for therapy failure in chronic myeloid leukemia patients receiving tyrosine kinase inhibitor therapy.]( Although tyrosine kinase inhibitor (TKI) therapy has markedly improved the survival of people with chronic-phase chronic myeloid leukemia (CML), 20-30% of people still experienced therapy failure.... [READ MORE]( [Channel Capacity of Genome-Wide Cell-Free DNA Fragment Length Distribution in Colorectal Cancer]( Each piece of cell-free DNA (cfDNA) has a length determined by the exact metabolic conditions in the cell it belonged to at the time of cell death. The changes in cellular regulation leading to a... [READ MORE]( [A Property of Everyday Health group]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Spec_Oncology_Update?xid=nl_mpt_Oncology_update_2024-07-26&mh=3c4cdd242849aa0e970f25e401732f81) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011